EM Clerkship

tPA (Deep Dive R29)

01.15.2022 - By Zack Olson, MD and Michael Estephan, MDPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

tPA usage is controversial. Listen to find out why. Read more to form your own opinions.

Episode Sources:

After Re-Analysis, No Trials Show Efficacy of tPA in Acute Ischemic Stroke

Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department

Why we can’t trust clinical guidelines – BMJ

Alteplase for Stroke: Money and Optimistic Claims Buttress the “Brain Attack” Campaign

Tissue Plasminogen Activator (tPA) for Acute Ischemic Stroke: Net benefits and harms unclear due to uncertainty in data – the NNT

More episodes from EM Clerkship